← All trials
NCT00755950
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2008
- Primary completion
- Nov 1, 2011
- Completion date
- Dec 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 70
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of MarylandLead sponsor
- University of MarylandOverall official - principal investigator
- University of MarylandStudy director
- University of MarylandStudy chair
- Alexandria UniversityCollaborator
- The Egyptian Company for Blood Transfusion ServicesCollaborator
- Banha Fever HospitalCollaborator
- Tanta UniversityCollaborator
- University of MarylandReponsible party - principal investigator
- Madaus IncCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.